Firms to supply 18.4 million doses of vaccines

PETALING JAYA: Malaysia has secured deals to acquire 18.4 million doses of Covid-19 vaccines through Pharmaniaga Bhd
.
In separate announcements, Pharmaniaga said it would be supplying 12 million doses of Covid-19 vaccines developed by China’s Sinovac Life Sciences Co Ltd, while Duopharma said it would supply 6.4 million doses of Sputnik V developed by Russia’s Gamaleya Research Institute to the government.
Both companies yesterday said they had entered into a term sheet agreements to supply the Covid-19 vaccines to the Health Ministry.
Pharmaniaga said it would begin manufacturing Sinovac Covid-19 vaccines in February and will deliver the bottled vaccines to identified hospitals and other healthcare facilities nationwide by April 2021.

Related Keywords

Malaysia ,Russia ,Petaling ,Malaysia General ,Russian ,Malaysians ,Pharmaniaga Bhd ,Pharmaniaga Lifescience ,Sinovac Covid ,Pharmaniaga Lifescience Sdn Bhd ,National Pharmaceutical Regulatory Agency On Jan ,National Pharmaceutical Regulatory Agency ,Health Ministry ,Russian Direct Investment Fund ,Russia Gamaleya National Research Institute Of Epidemiology ,Russia Gamaleya Research Institute ,Gamaleya Institute ,Drug Control Authority Malaysia ,China Sinovac Life Sciences Co Ltd ,Duopharma Biotech ,Sinovac Life Sciences Co Ltd ,Gamaleya Research Institute ,Bursa Malaysia ,National Pharmaceutical Regulatory ,Gamaleya National Research Institute ,Corporate News ,Duopharma ,Pharmaniaga ,Vaccines , ,மலேசியா ,ரஷ்யா ,இதழ்கள் ,மலேசியா ஜநரல் ,ரஷ்ய ,ஆரோக்கியம் அமைச்சகம் ,ரஷ்ய நேரடி முதலீடு நிதி ,மருந்து கட்டுப்பாடு அதிகாரம் மலேசியா ,தேசிய மருந்து ஒழுங்குமுறை ,பெருநிறுவன செய்தி ,தடுப்பு மருந்துகள் ,